| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sensei Biotherapeutics, Inc. (SNSE) has 6 insiders with recent SEC Form 4 filings, including 22 buys and 0 sells. SNSE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 1.24M | $17.16M | - | |
| Pres | 220.0K | $3.05M | - | |
| 10% | 130.1K | $1.80M | -25,000 | |
| 10% | 130.1K | $1.80M | -25,000 | |
| Other | 80.0K | $1.11M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 16, 2022 | Cambrian Biopharma Inc | 10% Owner | Buy | 12,551 | $4.19 | $52,641.75 | +0.1% | -60.2% | -66.0% | |
| Feb 11, 2022 | Cambrian Biopharma Inc | 10% Owner | Buy | 17,500 | $4.45 | $77,900.00 | +0.2% | -64.1% | -66.2% | |
| Feb 11, 2022 | Peyer James | Director, 10% Owner | Buy | 17,500 | $4.45 | $77,900.00 | +0.2% | -64.1% | -66.2% | |
| Feb 8, 2022 | Peyer James | Director, 10% Owner | Buy | 30,000 | $4.53 | $135,800.00 | +0.2% | -64.4% | -63.3% | |
| Feb 8, 2022 | Cambrian Biopharma Inc | 10% Owner | Buy | 30,000 | $4.53 | $135,800.00 | +0.2% | -64.4% | -63.3% | |
| Jan 28, 2022 | Cambrian Biopharma Inc | 10% Owner | Buy | 15,000 | $4.26 | $63,849.00 | +0.1% | -62.9% | -66.7% | |
| Jan 28, 2022 | Peyer James | Director, 10% Owner | Buy | 15,000 | $4.26 | $63,849.00 | +0.1% | -62.9% | -66.7% | |
| Jan 26, 2022 | Peyer James | Director, 10% Owner | Buy | 50,000 | $4.72 | $235,824.00 | +0.5% | -60.7% | -66.9% | |
| Jan 26, 2022 | Cambrian Biopharma Inc | 10% Owner | Buy | 50,000 | $4.72 | $235,824.00 | +0.5% | -60.7% | -66.9% | |
| Jan 24, 2022 | Cambrian Biopharma Inc | 10% Owner | Buy | 47,410 | $4.82 | $228,528.65 | +0.5% | -63.1% | -71.6% |